Study #2021-0037
Anti-Leukemia Immune Responses after Irradiation of Extramedullary Tumors
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This clinical trial assesses how the immune system responds to leukemia tumors after low dose radiation delivered as part of standard of care. The information learned in this study may help them know if adding immunotherapy (a type of treatment that uses the immune system to fight cancer) can be helpful in future leukemia patients receiving radiation.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Acute Myeloid Leukemia;Myeloid Leukemia;Recurrent Acute Myeloid Leukemia
Study phase:
Phase I (Early)
Physician name:
Bouthaina Dabaja
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.